Market research
OGI OrganiGram Holdings Inc
NASDAQ USD Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 133M
- P/E ratio
- 2.14
- Analyst target
- 8.8
- Dividend yield
- Not available
- Beta
- 1.91
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- CA68617J1003
- Market cap
- 133M
- P/E ratio
- 2.14
- Analyst target
- 8.8
- Dividend yield
- Not available
- Beta
- 1.91
About
About OrganiGram Holdings Inc
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.
Research context
OrganiGram Holdings Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the OGI discussion.
5 years, 6 months ago
OrganiGram Holdings Inc is currently in a long term uptrend where the price is trading 12.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.2.
OrganiGram Holdings Inc's total revenue sank by 23.1% to $19M since the same quarter in the previous year.
Its net income has dropped by 3878.7% to $-34M since the same quarter in the previous year.
Finally, its free cash flow grew by 96.6% to $-2M since the same quarter in the previous year.
Based on the above factors, OrganiGram Holdings Inc gets an overall score of 3/5.